Biotechnology Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson’s Disease Study – Cerevel Therapeutics Hldg (NASDAQ:CERE) Read more
Biotechnology Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson’s Data – Sage Therapeutics (NASDAQ:SAGE) Read more
Biotechnology Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson’s Disease Why Is Supernus Pharmaceuticals Stock Trading Lower on Monday> – Supernus Pharmaceuticals (NASDAQ:SUPN) Read more
Biotechnology Can The Eyes Indicate A Disease Like Parkinson’s? – Axim Biotechnologies (OTC:AXIM) Read more
Biotechnology Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD 2024 International Conference – Athira Pharma (NASDAQ:ATHA) Read more
Biotechnology NodThera’s NLRP3 Inhibitor NT-0796 Reverses Neuroinflammation in Parkinson’s Disease Phase Ib/IIa Trial Read more
Biotechnology EXCLUSIVE: Gain Therapeutics Highlights Lead Program Data Showcasing Its Impact On Cellular Death For Treating Parkinson’s Disease – Gain Therapeutics (NASDAQ:GANX) Read more